Population-based data on Parkinson's disease reported by Mayeux et al. (1, 2) suggest continually increasing age-specific Parkinson's disease incidence rates, even for very old persons (persons aged >84 years), and also identify incidence differences by race/ethnic affiliation. In a 30-year Parkinson's disease incidence study in a cohort of 8,006 American men of Japanese or Okinawan ancestry (3, 4), we found annual incidence rates nearly identical to the total rates of Mayeux et al. in the age ranges of 65-74 years (55.6 per 100,000 personyears in our study vs. 54.2 in theirs) and 75-84 years (132.4 vs. 136.6 (1, 2)). In men aged >84 years, however, Mayeux et al. report an incidence rate higher by more than fourfold (77.8 vs. 353.8), attributable disproportionately to incident cases in black and Hispanic men.
years, the rates remain within a twofold range. However, the rates diverge from three-to 12-fold at ages >85 years. The argument for racial/ethnic differences in men thus rests strongly on case detection among the most elderly men. There may be several possible explanations for the apparent incidence differences. Differential diagnostic accuracy could be consistent with the findings by Mayeux et al. that black men had higher Parkinson's disease incidence rates, but lower prevalence rates, than other men, to a degree not easily explained by differential mortality. In-or outmigration differences might also produce such an incidence disparity; for example, the 3-year residency requirement for enrollment, undoubtedly longer than the interval between symptom onset and diagnosis for many subjects, might have allowed non-black persons with "prediagnostic" Parkinson's disease to preferentially "escape" from the catchment area before they could be diagnosed. Diagnostic delay in black persons could also explain the differences. Mayeux et al. report that the mean age of symptom onset in incident cases (75.2 years) was nearly 10 years older than for prevalent cases (65.7 years). Such incident cases could have been experiencing "catchup" diagnoses; some of the alternative explanations for the mean age differences (e.g., that extraordinarily high Parkinson's disease mortality affects only older patients or that the epidemiology of Parkinson's disease has changed dramatically in the past few years) seem less likely to us. These concerns underscore the difficulties in characterizing the basic descriptive epidemiology of Parkinson's disease.
